{8 (selinexor 50 MG Oral Tablet) } Pack

RxCUI: 2548739
RxNorm name: {8 (selinexor 50 MG Oral Tablet) } Pack
Display name: {8 (selinexor 50 MG Oral Tablet) } Pack
Full name: {8 (selinexor 50 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
XPOVIO	SELINEXOR	Karyopharm Therapeutics Inc.	f6dd2682-75a6-4863-90a8-a3197f6f78a8	2026-05-12	Warnings, Adverse reactions	Exact identifier rxcui: 2548739

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f6dd2682-75a6-4863-90a8-a3197f6f78a8	{8 (selinexor 50 MG Oral Tablet) } Pack [GPCK] · selinexor 100 MG Weekly Dose Carton Pack, 50 MG oral Tablet 8 Count Pack [PSN] · selinexor 100 MG Weekly Dose Carton Pack, 4 Blister Cards, 2 Tablets Each [SY]	3	18	These highlights do not include all the information needed to use XPOVIO safely and effectively. See full prescribing information for XPOVIO. XPOVIO ® (selinexor) tablets, for oral use Initial U.S. Approval: 2019	20260512